Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Blend · Fidelity

BIVSX Expense Ratio & Fees

Ticker BIVSX · Since 2019-05-10 · · Holdings as of Jul 31, 2026

Expense ratio
2.8%$280/yr per $10k
5-yr return
+22.2%annualized
1-yr return
+4.9%as of Dec 2025
Net assets
$854.8Mall share classes
Holdings
219

Bottom line

What is BIVSX's expense ratio?

BIVSX's expense ratio is 2.8%, or about $280 a year on every $10,000 invested. That is more expensive than 98% of large blend funds we track (median 0.83%). It has no front-end sales load.

Updated Mar 2, 2026

BIVSX fee table

Net expense ratio2.8%
Gross expense ratio2.82%
Management fee1.74%
12b-1 (distribution) fee0%
Other expenses1.07%
Acquired fund fees0.01%
Fee waiver / reimbursement-0.02%
Max front-end sales load0%
Max deferred sales charge0%
Redemption fee-1%

Source: Fund prospectus fee table, filed Mar 2, 2026

What BIVSX costs in dollars

The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:

1 year3 years5 years10 years
BIVSX$283$872$1,487$3,146

Source: Fund prospectus expense example

The long-run cost of fees

On $100,000 growing at 6% a year for 20 years, a 2.8% expense ratio costs roughly $133,000 in lost growth, versus about $46,700 for the median large blend fund (0.83%).

Cheapest way to own Invenomic Fund

All share classes
TickerClassExpense ratioFront load
BIVSXInvenomic Fund Super Institutional Class shares2.8%0%
BIVIXInvenomic Fund Institutional Class shares3.05%0%
BIVRXInvenomic Fund Investor Class shares3.3%0%